Skip to main content
Transcenta Holding Limited logo

Transcenta Holding Limited — Investor Relations & Filings

Ticker · 6628 ISIN · KYG9005B1041 HKEX Manufacturing
Open in API
Filings indexed 482 across all filing types
Latest filing 2025-09-12 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 6628

About Transcenta Holding Limited

http://www.transcenta.com

Transcenta Holding Limited is a clinical-stage global biotherapeutics company specializing in the discovery, research, development, and manufacturing of differentiated antibody-based therapeutics. The company operates a fully integrated platform, utilizing a unique antibody generation platform based on Immune Tolerance Breaking Technology to generate candidate leads. Its robust pipeline includes therapeutic antibody molecules targeting oncology and selected non-oncology indications, such as bone and kidney disorders. The company employs advanced bioprocessing technologies, including perfusion-based continuous bioprocessing, to accelerate process development and reduce manufacturing costs.

Recent filings

Filing Released Lang Actions
NOTIFICATION LETTER AND REPLY FORM TO REGISTERED HOLDERS
Report Publication Announcement Classification · 92% confidence The document is a notification letter to registered shareholders announcing the publication of the Company’s 2025 Interim Report and providing instructions on how to access it online or request printed copies, including a reply form. It does not contain the report’s financial content itself but rather serves to notify shareholders that the interim report is available (“Notification of publication”). Therefore, it is a Report Publication Announcement.
2025-09-12 English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS
Report Publication Announcement Classification · 87% confidence The document is a notification letter informing non-registered shareholders that the company’s 2025 Interim Report is available on its website and the stock exchange site, with instructions on how to request printed copies. It does not contain the interim report itself but merely announces its publication and provides a request form for printed communications. According to the filing definitions, this corresponds to a Report Publication Announcement (RPA).
2025-09-12 English
2025 INTERIM REPORT
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report 2025' for Transcenta Holding Limited. It contains comprehensive financial highlights, business highlights, and references to condensed consolidated financial statements for the six months ended June 30, 2025. It is a full interim report, not an announcement or a summary, and fits the definition of an Interim/Quarterly Report (IR). H1 2025
2025-09-12 English
PLACING OF NEW SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change Classification · 90% confidence The document is an announcement by a Hong Kong listed company detailing the terms of a placing of new shares under the company’s general mandate, including number of shares, pricing, conditions precedent, lock-up arrangements, and intended use of proceeds. This is clearly an equity issuance announcement, matching the definition of Share Issue/Capital Change (SHA).
2025-09-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025
Regulatory Filings Classification · 88% confidence The document is an HKEX Form FF301 “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts” under Chapter 19B of the Listing Rules, detailing monthly movements in authorised share capital, issued and treasury shares, share options, RSUs, etc. It is a routine regulatory filing to the exchange rather than an AGM presentation, earnings release, annual or interim report, management discussion, investor presentation, major shareholding notification, or dividend notice. It does not announce a one-off share placement but provides the standard monthly return of share capital movements. Therefore it falls under the fallback category “Regulatory Filings (Code: RNS).”
2025-09-04 English
(1) INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025&#x3b; AND (2) CHANGE IN USE OF PROCEEDS
Interim / Quarterly Report Classification · 100% confidence The document is an 'Interim Results Announcement' for Transcenta Holding Limited for the six months ended June 30, 2025. It contains detailed financial highlights (IFRS and Non-IFRS measures), business highlights, and clinical program updates. As it provides comprehensive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H2 2025
2025-08-27 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.